Trending Articles
-
Asian J Transfus Sci · Jan 2010
Coagulation parameters as a guide for fresh frozen plasma transfusion practice: A tertiary hospital experience.
The appropriate use of blood and blood products means the transfusion of safe blood products only to treat a condition leading to significant morbidity or mortality, which cannot be prevented or managed effectively by other means. The safety and effectiveness of transfusion depend on the appropriate clinical use of blood and blood products. This study was conducted to review the practice of fresh frozen plasma usage (FFP) for transfusion, based on the coagulation profile, requested by various departments in the Hospital Universiti Sains Malaysia (HUSM). ⋯ Our results showed that a significant proportion of the FFP transfusion was not guided by the coagulation profile. We recommend that a continuous education on FFP transfusion may help to guide the appropriate request for FFP.
-
J Pain Symptom Manage · Apr 2019
Pediatric Palliative Care in the Multi-Cultural Context: Findings from a workshop conference.
In our increasingly multicultural society, providing sensitive and respectful pediatric palliative care is vital. ⋯ Taken together, findings provide a foundation for collaboration between patients, families, and clinicians of all cultures.
-
Chinese medical journal · Jan 2020
Combined detection of urine specific gravity and BK viruria on prediction of BK polyomavirus nephropathy in kidney transplant recipients.
BK polyomavirus (BKPyV)-associated nephropathy (BKPyVAN) is an important cause of dysfunction and failure of renal transplants. This study aimed to assess the diagnostic performance of morning urine specific gravity (MUSG) in diagnosing BKPyVAN in kidney transplant recipients. ⋯ Combined detection of MUSG and BKPyV viruria is valuable for predicting BKPyVAN and distinguishing BKPyVAN from TCMR in renal transplant recipients.
-
J Strength Cond Res · Aug 2003
Clinical Trial Controlled Clinical TrialEffect of creatine supplementation on intermittent sprint running performance in highly trained athletes.
This study examined the impact of short-term (7-day), high-dose (0.35 g.kg(-1).d(-1)) oral creatine monohydrate supplementation (CrS) on single sprint running performance (40 m, <6 seconds) and on intermittent sprint performance in highly trained sprinters. Nine subjects completed the double-blind cross-over design with 2 supplementation periods (placebo and creatine) and a 7-week wash-out period. ⋯ There were no significant changes related to CrS in absolute running velocity at any distance between start and finish (40 m). It was concluded that no ergogenic effect on single or repeated 40-m sprint times with varying rest periods was observed in highly trained athletes.